Bristol-Myers Escapes Abilify Movement Disorder Suit

By Greg Ryan (December 5, 2013, 6:13 PM EST) -- A Pennsylvania federal judge on Monday dismissed a man's lawsuit against Bristol-Myers Squibb Co. over a movement disorder he developed after taking the drug Abilify, saying that drugmakers are not required to provide detailed instructions to physicians about monitoring for adverse reactions.

Plaintiff Ryan Bergstresser claimed that Bristol-Myers failed to provide information in Abilify's package insert about monitoring for dystonia, a muscular disease marked by involuntary muscle contractions. Bergstresser allegedly suffers from permanent dystonia caused by Abilify he took to treat his depression.

U.S. District Judge Malachy Mannion ruled that the Code of Federal Regulations does not mandate that drugmakers include...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!